RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-838
Malaria parasiteP. yoelii
Genotype
DisruptedGene model (rodent): PY17X_1114100; Gene model (P.falciparum): PF3D7_0513300; Gene product: purine nucleoside phosphorylase (PNP)
Phenotype Asexual bloodstage; Oocyst; Sporozoite;
Last modified: 1 December 2013, 10:46
  *RMgm-838
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 18758447
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. yoelii
Parent strain/lineP. y. yoelii YM
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherTing, L.M.; Kim, K.
Name Group/DepartmentDepartment of Medicine and Microbiology
Name InstituteAlbert Einstein College of Medicine
CityNew York
CountryUSA
Name of the mutant parasite
RMgm numberRMgm-838
Principal nameΔPyPNP-INT; ΔPyPNP-GFP
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageAll wild type (WT)-infected mice developed high parasitemias and died within 10 d of challenge. ΔPyPNP and ΔPyPNP-GFP parasites had no detectable impairment of intraerythrocytic development, but growth of these lines was impaired compared to that of WT parasites. None of the parasite lines lacking PNP were lethal to mice, and infected mice recovered from infection with no detectable parasitemia.
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot tested
OocystStrongly reduced numbers of oocysts. No salivary gland sporozoites.
SporozoiteStrongly reduced numbers of oocysts. No salivary gland sporozoites.
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of purine nucleoside phosphorylase (PNP).
(gene model in P. yoelii YM: PYYM_1115100)

Protein (function)
Unlike their mammalian hosts, malaria parasites cannot synthesize purines de novo and depend exclusively on purine salvage and recycling for RNA and DNA synthesis. The purine salvage pathway is streamlined in Plasmodium, composed of only adenosine deaminase (ADA), purine nucleoside phosphorylase (PNP) and hypoxanthine-guanine-xanthine phosphoribosyltransferase. Hypoxanthine is a  precursor for all purines and a central metabolite for nucleic acid synthesis in P.  falciparum. The dual action of P. falciparum ADA and PNP for purines and methylthiopurines allows the parasite to form hypoxanthine from host purine pools and to recycle hypoxanthine from methylthioadenosine, a product of polyamine synthesis. P. falciparum ADA and PNP function at the intersection of the polyamine metabolism and purine salvage pathways

Phenotype
All wild type (WT)-infected  mice developed high parasitemias and died within 10 d of challenge. ΔPyPNP and ΔPyPNP-GFP parasites had no detectable impairment of intraerythrocytic development, but growth of these lines was impaired compared to that of WT parasites. None of the parasite lines lacking PNP were lethal to mice, and infected mice recovered from infection with no detectable parasitemia.

No detailed information is provided on gametocyte or ookinete production. Mosquitoes fed on mice with gametocytes showed strongly reduced numbers of oocysts. No sporozoites were found in the salivary gland sporozoites.

Additional information
Two PyPNP-knockout mutants were generated by targeting the WT pnp genomic locus with PCR generated deletion constructs designed to replace the coding region of the pnp gene with either the hdhfr selection cassette (ΔPypnp) or the hdhfr/gfp selection cassette (ΔPypnpGFP) via double cross-over homologous recombination between 5’-fragment and 3’-fragment of the pnp locus that flank the selection cassette.

See also RMgm-837  for a P. berghei ANKA mutant lacking expression of PNP. This mutant  shows normal growth and multiplication of blood stages and parasites induce experimental cerebral malaria in C57BL/6 mice.

Other mutants
RMgm-837: a P. berghei ANKA mutant lacking expression of PNP


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PY17X_1114100
Gene Model P. falciparum ortholog PF3D7_0513300
Gene productpurine nucleoside phosphorylase
Gene product: Alternative namePNP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct usedPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid BseRI
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationFor deletion of pnp locus by replacement, a PCR-based approach for generation of gene targeting constructs for P. berghei was adapted for P. yoelii. Two PCR reactions: PCRI and PCRII, required to generate the complete constructs, were carried out by using the Advantage 2 Polymerase Mix (BD Biosciences) and Long Template PCR Polymerase Mix (Roche), respectively, according to the manufacturer’s instructions. PCR I amplified two flanking fragments of homology to the pnp gene from P. yoelii genomic DNA using primer combination of Pypnp-5’-F and Pypnp-5’-R or primer combination of Pypnp-5’-F and PypnpGFP-5’-R for the 5’-upstream region and primer combination of Pypnp-3’-F and Pypnp-3’-R or primer combination of PypnpGFP-3’-F and Pypnp-3’-R for the 3’-downstream region of pnp gene. Primers Pypnp-5’-R and Pypnp-3’-F have 5’-terminal extensions homologous to the selection cassette hdhfr of pL006 (kindly provided by Andy Waters and Chris Janse, Leiden); primers PypnpGFP-5’-R and PypnpGFP-3’-F have 5’ terminal extensions homologous to the selection cassette hdhfr/gfp of pHDGFP. For PCR II, the pnp 5’ and 3’ flanking fragments (1.5 kb each) with corresponding extensions from PCR I were combined with either ScalI-linearized pL006 or ScalI- linearized pHDGFP with the outer primers 5’-Pypnp-F and 3’-Pypnp-R. This leads to the amplification of the complete gene targeting constructs for deletion of pnp
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6